This reissued K43 award supports emerging global leaders conducting independent clinical trials. It aligns with clinical trials policy and aims to develop clinical research leadership. The award facilitates independent clinical trial research projects by emerging investigators.
Eligibility details are not fully specified; applicants should refer to the "Additional Information on Eligibility" section for clarification. The opportunity is likely limited to U.S. applicants due to federal funding and inferred national scope.
